The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Boytsov S.A.

National Research Centre for Preventive Medicine, Moscow, Russia

Deev A.D.

"GNITs profilakticheskoĭ meditsiny" Minzdrava Rossii

Shalnova S.A.

National Medical Research Center for Preventive Medicine, Moscow, Russia

Mortality and risk factors for non-communicable diseases in Russia: Specific features, trends, and prognosis

Authors:

Boytsov S.A., Deev A.D., Shalnova S.A.

More about the authors

Journal: Therapeutic Archive. 2017;89(1): 5‑13

Read: 7668 times


To cite this article:

Boytsov SA, Deev AD, Shalnova SA. Mortality and risk factors for non-communicable diseases in Russia: Specific features, trends, and prognosis. Therapeutic Archive. 2017;89(1):5‑13. (In Russ.)
https://doi.org/10.17116/terarkh20178915-13

Recommended articles:
Risk factors asso­ciated with myopic macu­lopathy in acquired myopia. Russian Annals of Ophthalmology. 2024;(5):35-45
Features of como­rbidity pathology in young people. Russian Journal of Preventive Medi­cine. 2024;(11):63-69
Intracranial hype­rtension in hemo­rrhagic stroke: a single-center retrospective study. Russian Journal of Anesthesiology and Reanimatology. 2024;(6):23-29
Comparison of models for prediction of spontaneous preterm birth. Medi­cal Technologies. Asse­ssment and Choice. 2024;(4):10-19
COVID-19 and pneumonia — mortality and coding features (example of the Moscow region). Medi­cal Technologies. Asse­ssment and Choice. 2024;(4):30-39
Gastric cancer: inci­dence, risk factors, screening. Russian Journal of Preventive Medi­cine. 2024;(12):135-139
Features of primary and recu­rrent ischemic stroke in men aged 18—50 years. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):65-74

References:

  1. Omran AR. The Epidemiologic Transition: A Theory of the Epidemiology of Population Change. Milbank Mem Fund Q. 1971;49:509-538. doi:10.2307/3349375
  2. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M et al. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. The Lancet. 1999;353(9164):1547-1557. doi:10.1016/s0140-6736(99)04021-0
  3. Boytsov S. Mechanisms of reduction in coronary heart disease mortality in different countries of the world. Preventive medicine. 2013;16(5):9-19.
  4. Gogin E. Gipertonicheskaya bolezn'. M.: MC UPD Prezidenta Rossiiskoi Federacii; 1997. ISBN 5-206-00573-8
  5. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. European Heart Journal. 2016;37(29):2315-2381. doi:10.1093/eurheartj/ehw106
  6. Shal'nova S, Deev A, Metel'skaya V, Evstifeeva S, Rotar' O, Zhernakova Yu, Boicov S ot imeni uchastnikov issledovaniya ESSE-RF. Informirovannost' i osobennosti terapii statinami u lic s razlichnym serdechno-sosudistym riskom po dannym issledovaniya ESSE-RF. Kardiovaskulyarnaya terapiya i profilaktika. 2016;4:(в печати)
  7. Boytsov S, Samorodskaya I, Tret'yakov V. Gradient smertnosti v vozraste 40—59 let v sub'ektah Rossiiskoi Federacii. Vestnik Rossiiskoi akademii medicinskih nauk. 2014;69(7-8):106-111. doi:10.15690/vramn.v69i7-8.1116
  8. Muromceva G, Koncevaya A, Konstantinov V, Artamonova G, Gatagonova T, Duplyakov D, Efanov A, Zhernakova Yu, Il'in V, Konradi A, Libis R, Minakov A, Nedogoda S, Oshepkova E, Romanchuk S, Rotar' O, Trubacheva I, Deev A, Shal'nova S, Chazova E, Shlyahto E, Boicov S. Rasprostranennost' faktorov riska neinfekcionnyh zabolevanii v rossiiskoi populyacii v 2012—2013 gg. Rezul'taty issledovaniya ESSE-RF. Kardiovaskulyarnaya terapiya i profilaktika. 2014;13(6):4-11. doi:10.15829/1728-8800-2014-6-4-11
  9. Shal'nova S, Deev A, Balanova Yu, Zhernakova Yu, Konradi A, Boytsov S ot imeni uchastnikov issledovaniya «ESSE-RF» Lechenie gipertonii u pacientov vysokogo riska. Monoterapiya ili kombinaciya? Lechashii vrach. 2016
  10. Dedov I, Shestakova M, Vikulova O. Gosudarstvennyi registr saharnogo diabeta v Rossiiskoi Federacii: status 2014 g. i perspektivy razvitiya. Saharnyi diabet. 2015;18(3):5-23. doi:10.14341/DM201535-22
  11. Critchley J, Liu J, Zhao D, Wei W, Capewell S. Explaining the Increase in Coronary Heart Disease Mortality in Beijing Between 1984 and 1999. Circulation. 2004;110(10):1236-1244. doi:10.1161/01.cir.0000140668.91896.ae
  12. Laatikainen T, Jula A, Jousilahti P. National Institute for Health and Welfare (THL) — Data Brief 25/2015. Accessed August 12, 2016. https://www.julkari.fi/bitstream/handle/10024/126519/URN_ISBN_978-952-302-511-0.pdf?sequence=1
  13. Laatikainen T, Jula A, Jousilahti P. National Institute for Health and Welfare (THL) — Data Brief 26, 2015. Accessed August 12, 2016. Available at: https://www.julkari.fi/bitstream/handle/10024/126520/URN_ISBN_978-952-302-512-7.pdf?sequence=1
  14. Global action plan for the prevention and control of noncommunicable diseases 2013-2020. WHO; 2013. ISBN 978 92 4 150623 6. Accessed August 12, 2016. Available at: http://apps.who.int/iris/bitstream/10665/94384/1/9789241506236_eng.pdf

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.